Explore the case study below, which highlights how simple RADiant makes treatment of both squamous cell carcinoma and basal cell carcinoma lesions in the dermatology clinic setting.
Maui Derm Hawaii 2025 to Feature Xstrahl’s Dual Modality Treatment Solution for Dermatologists
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will feature Radiant Aura at the Maui Derm Hawaii 2025 meeting, January 20-24, 2025. Radiant Aura is a low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring.
